10-Q/A: ALT5 Sigma Amends 10-Q, Addresses Nasdaq Delinquency

ALT5 Sigma Corporation filed an amendment to its quarterly report, primarily to address a Nasdaq delinquency notice regarding its delayed annual stockholder meeting.

Summary

• ALT5 Sigma Corporation filed Amendment No. 1 to its Quarterly Report on Form 10-Q for the quarter ended September 27, 2025.
• The amendment's primary purposes include removing a sentence from Item 1A, updating the company's name in Exhibits 31.1 and 31.2, and correcting a dating typographical error in Exhibits 32.1 and 32.2.
• The company received a delinquency notification letter from the Nasdaq Stock Market LLC on January 7, 2026, for non-compliance with Listing Rules 5620(a) and 5810(c)(2)(G).
• The non-compliance stems from the company's failure to hold an annual meeting of stockholders within twelve months of its fiscal year-end.
• ALT5 Sigma previously announced on January 2, 2026, that its Annual Meeting of Stockholders is scheduled for February 27, 2026.
• The company is required to submit a plan to regain compliance within 45 days of the January 7, 2026 letter.
• If the compliance plan is accepted, the company will have 180 calendar days, or until June 26, 2026, to cure the deficiency.
• ALT5 Sigma intends to file a compliance plan and resolve the deficiency by holding its Annual Meeting of Stockholders on February 27, 2026.
• The delinquency notice has no immediate effect on the listing or trading of the company's common stock on The Nasdaq Capital Market.

Sentiment

Score: 4

Explanation: The filing addresses a significant corporate governance issue (Nasdaq delinquency notice) which is a negative. However, the company has a stated plan to cure the deficiency and there is no immediate impact on trading, which mitigates the severity. The amendment itself is for minor corrections.

Positives

• The company has a clear plan to cure the Nasdaq listing deficiency by holding its Annual Meeting of Stockholders on February 27, 2026.
• The Nasdaq delinquency notice has no immediate effect on the listing or trading of the company's common stock.

Negatives

• Received a delinquency notification from Nasdaq on January 7, 2026, for non-compliance with listing rules due to the failure to hold an annual meeting of stockholders within the required timeframe.

Risks

• Risk of potential delisting from The Nasdaq Capital Market if the company fails to regain compliance with Nasdaq Listing Rules 5620(a) and 5810(c)(2)(G) by the June 26, 2026 deadline.
• The company is a smaller reporting company and does not provide detailed risk factor disclosures in this item, which may limit investor insight into other potential risks.

Future Outlook

The company intends to file a plan of compliance with Nasdaq within 45 days of the delinquency notice and cure the deficiency by holding its Annual Meeting of Stockholders on February 27, 2026. If the plan is accepted, the company will have until June 26, 2026, to regain full compliance.

Management Comments

• "Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report." (Tony Isaac, Acting CEO, and Steven Plumb, CFO)
• "Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of and for the periods presented in this report." (Tony Isaac, Acting CEO, and Steven Plumb, CFO)
• "The Company intends to file a plan of compliance, and cure the deficiency by holding its Annual Meeting of Stockholders on February 27, 2026."

Industry Context

This filing is primarily a compliance-related amendment and does not directly reflect broader industry trends. However, maintaining Nasdaq listing compliance is crucial for public companies, especially smaller reporting companies, to ensure liquidity and investor confidence, a standard expectation across all industries.

Corporate Governance

Stakeholder Impact

• Shareholders: Face potential risk of delisting if compliance is not regained, which could impact liquidity and share value. However, the company's plan to cure the deficiency aims to mitigate this risk.
• Nasdaq: The company's non-compliance impacts Nasdaq's listing standards and oversight.

Next Steps

• Submit a plan to Nasdaq regarding regaining compliance within 45 days of January 7, 2026.
• Hold the Annual Meeting of Stockholders on February 27, 2026.
• Regain full compliance with Nasdaq listing rules by June 26, 2026, if the plan is accepted.

Key Dates

Recommendation

While the Nasdaq delinquency notice is a negative event indicating a lapse in corporate governance, the company has a clear and immediate plan to cure the deficiency by holding its annual meeting. There is no immediate impact on trading. Investors should monitor the company's progress in regaining compliance, but the current situation does not warrant an immediate 'sell' given the stated corrective actions. A 'hold' is appropriate pending successful resolution of the compliance issue.

Keywords

ALT5 Sigma, ALTS, Nasdaq, 10-Q/A, SEC filing, Quarterly Report, Compliance, Annual Meeting, Corporate Governance, Delinquency Notice, Stock Market, Financial Reporting